A novel iron(II) phenanthroline complex exhibits anticancer activity against TFR1-overexpressing esophageal squamous cell carcinoma cells through ROS accumulation and DNA damage | |
Ye, Jiecheng; Ma, Jiwei; Liu, Chan; Huang, Jianxian; Wang, Lihui; Zhong, Xueyun | |
刊名 | BIOCHEMICAL PHARMACOLOGY |
2019 | |
卷号 | 166页码:93-107 |
关键词 | Iron(II) phenanthroline complex Transferrin receptor 1 Esophageal squamous cell carcinoma Reactive oxygen species DNA damage Thioredoxin reductase |
DOI | 10.1016/j.bcp.2019.05.013 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4546174 |
专题 | 山东大学 |
作者单位 | Jinan Univ, Med Coll, Dept Pathol, Guangzhou 510632, Guangdong, Peoples R China |
推荐引用方式 GB/T 7714 | Ye, Jiecheng,Ma, Jiwei,Liu, Chan,et al. A novel iron(II) phenanthroline complex exhibits anticancer activity against TFR1-overexpressing esophageal squamous cell carcinoma cells through ROS accumulation and DNA damage[J]. BIOCHEMICAL PHARMACOLOGY,2019,166:93-107. |
APA | Ye, Jiecheng,Ma, Jiwei,Liu, Chan,Huang, Jianxian,Wang, Lihui,&Zhong, Xueyun.(2019).A novel iron(II) phenanthroline complex exhibits anticancer activity against TFR1-overexpressing esophageal squamous cell carcinoma cells through ROS accumulation and DNA damage.BIOCHEMICAL PHARMACOLOGY,166,93-107. |
MLA | Ye, Jiecheng,et al."A novel iron(II) phenanthroline complex exhibits anticancer activity against TFR1-overexpressing esophageal squamous cell carcinoma cells through ROS accumulation and DNA damage".BIOCHEMICAL PHARMACOLOGY 166(2019):93-107. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论